05.02.2020Researchers at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and partners in Hungary have studied the response to targeted leukemia therapy in unprecedented detail, using single-cell sequencing and epigenetic analysis.
20.01.2020A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia (AML), one of the most common forms of blood cancer. This is the conclusion of a study in mice and human blood cells performed at Karolinska Institutet and SciLifeLab and published in the medical journal EMBO Molecular Medicine.
09.01.2020Artificial intelligence can detect one of the most common forms of blood cancer – acute myeloid leukemia (AML) – with high reliability. Researchers at the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn have now shown this in a proof-of-concept study. Their approach is based on the analysis of the gene activity of cells found in the blood.